Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
96 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//INFECTIOUS DISEASES | 26037 |
3308 | 1 | ZIDOVUDINE//DIDANOSINE//DIDEOXYINOSINE | 2046 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ZIDOVUDINE | authKW | 737893 | 11% | 22% | 221 |
2 | DIDANOSINE | authKW | 323395 | 4% | 28% | 76 |
3 | DIDEOXYINOSINE | authKW | 157708 | 1% | 64% | 16 |
4 | STAVUDINE | authKW | 157242 | 3% | 19% | 53 |
5 | ZALCITABINE | authKW | 138071 | 1% | 39% | 23 |
6 | 2 3 DIDEOXYINOSINE | authKW | 123629 | 1% | 47% | 17 |
7 | LAMIVUDINE | authKW | 107207 | 5% | 7% | 101 |
8 | AZIDOTHYMIDINE | authKW | 94615 | 1% | 24% | 26 |
9 | AZT | authKW | 93303 | 2% | 13% | 48 |
10 | EMTRICITABINE | authKW | 66790 | 1% | 16% | 27 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 9301 | 40% | 0% | 815 |
2 | Infectious Diseases | 7585 | 19% | 0% | 380 |
3 | Virology | 3029 | 10% | 0% | 197 |
4 | Immunology | 2165 | 17% | 0% | 345 |
5 | Chemistry, Analytical | 2001 | 15% | 0% | 299 |
6 | Microbiology | 1984 | 14% | 0% | 289 |
7 | Biochemical Research Methods | 1439 | 10% | 0% | 197 |
8 | Medicine, General & Internal | 576 | 9% | 0% | 190 |
9 | Toxicology | 94 | 3% | 0% | 58 |
10 | Hematology | 68 | 3% | 0% | 53 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHARMACOL IMMUNOL UNIT | 38501 | 0% | 50% | 5 |
2 | I TECH SERV | 35202 | 0% | 57% | 4 |
3 | MED M862 | 35202 | 0% | 57% | 4 |
4 | CANC TREATMENT CLIN ONCOL PROGRAM | 34654 | 0% | 75% | 3 |
5 | CLETS | 34654 | 0% | 75% | 3 |
6 | RADIAT THERMAL BIOL | 30805 | 0% | 100% | 2 |
7 | WORLDWIDE CLIN PHARMACOL | 30801 | 0% | 50% | 4 |
8 | ROOM 5B22 | 20535 | 0% | 67% | 2 |
9 | CLIN PHARMACOL DATA SCI | 19800 | 0% | 43% | 3 |
10 | 8B SUR 3710 | 15402 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 20784 | 2% | 4% | 34 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 16269 | 8% | 1% | 161 |
3 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 15624 | 2% | 2% | 43 |
4 | ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 15018 | 1% | 4% | 22 |
5 | AIDS | 6872 | 3% | 1% | 63 |
6 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 5351 | 3% | 1% | 66 |
7 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 4449 | 2% | 1% | 40 |
8 | DRUG METABOLISM AND DISPOSITION | 2288 | 2% | 0% | 34 |
9 | ANTIVIRAL RESEARCH | 2221 | 1% | 1% | 23 |
10 | JOURNAL OF INFECTIOUS DISEASES | 2063 | 2% | 0% | 50 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ZIDOVUDINE | 737893 | 11% | 22% | 221 | Search ZIDOVUDINE | Search ZIDOVUDINE |
2 | DIDANOSINE | 323395 | 4% | 28% | 76 | Search DIDANOSINE | Search DIDANOSINE |
3 | DIDEOXYINOSINE | 157708 | 1% | 64% | 16 | Search DIDEOXYINOSINE | Search DIDEOXYINOSINE |
4 | STAVUDINE | 157242 | 3% | 19% | 53 | Search STAVUDINE | Search STAVUDINE |
5 | ZALCITABINE | 138071 | 1% | 39% | 23 | Search ZALCITABINE | Search ZALCITABINE |
6 | 2 3 DIDEOXYINOSINE | 123629 | 1% | 47% | 17 | Search 2+3+DIDEOXYINOSINE | Search 2+3+DIDEOXYINOSINE |
7 | LAMIVUDINE | 107207 | 5% | 7% | 101 | Search LAMIVUDINE | Search LAMIVUDINE |
8 | AZIDOTHYMIDINE | 94615 | 1% | 24% | 26 | Search AZIDOTHYMIDINE | Search AZIDOTHYMIDINE |
9 | AZT | 93303 | 2% | 13% | 48 | Search AZT | Search AZT |
10 | EMTRICITABINE | 66790 | 1% | 16% | 27 | Search EMTRICITABINE | Search EMTRICITABINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |